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Abstract
Background: Porcine reproductive and respiratory syndrome (PRRS) is caused by porcine reproductive and respiratory
syndrome virus (PRRSV) and is an economically important disease in swine-producing areas. The objective of this study
was to screen for effective antisense oligonucleotides (AS-ONs) which could inhibit PRRSV replication in MARC-145 cells
and in pulmonary alveolar macrophages (PAM).
Results: Nine short AS-ON sequences against the well-conserved regions of PRRSV (5′-UTR, NSP9, ORF5 and ORF7)
were selected. When MARC-145 cells or PAM were infected with PRRSV followed by transfection with AS-ONs, four
AS-ON sequences targeting 5′-UTR, ORF5 or NSP9 were found to be the most effective oligonucleotides in decreasing
the cytopathic effect (CPE) induced by PRRSV infection. Quantitative PCR and indirect immunofluorescence staining
confirmed that ORF7 levels were significantly reduced both at RNA and protein levels. The PRRSV titration data
furthermore indicated that transfection with AS-ON YN8 could reduce the PRRSV titer by 1000-fold compared
with controls.
Conclusion: The results presented here indicate that DNA-based antisense oligonucleotides can effectively inhibit
PRRSV replication in MARC-145 cells and in PAM. Furthermore, comparing with the reported hit rates (approximately
10-30 %), we achieved a higher success rate (44 %). The strategy we took to design the antisense sequences might be
applied to select AS-ONs that more efficiently reduce the expression of target genes.
Keywords: Porcine reproductive and respiratory syndrome virus (PRRSV), Virus replication, Antisense oligonucleotides,
Marc-145, Pulmonary alveolar macrophages (PAM)
Background
Porcine reproductive and respiratory syndrome (PRRS)
is one of the most economically significant viral diseases
in the swine industry, which is characterized by respira-
tory disorders in piglets and reproductive failure in sows
[1]. This disease is due to the infection by porcine repro-
ductive and respiratory syndrome virus (PRRSV), which
belongs to the family Arteriviridae, genus Arterivirus [2].
PRRSV is an enveloped single-stranded positive-sense
RNA virus. The genome of PRRSV is approximately
15 kb in length and consists of nine open reading frames
(ORFs) [3]. ORF1a and ORF1b are located at the 5′ end
of the genome and encode proteins with replicase and
polymerase activities. NSP9 is a putative RNA-dependent
RNA polymerase and plays important roles in viral
replication [4]. ORFs 2–7 are located at the 3′-end of
the genome and encode the structural proteins [2].
ORF5 encodes the GP5 protein, a receptor-binding
protein [3, 5] which is a primary antigenic envelope
glycoprotein. GP5 is targeted by the cellular immune
response and is critical for viral neutralization function-
ing as. ORF7 encodes the nucleocapsid protein N which
is important for the assembly and disassembly of the
virion [6]. It is reasonable to speculate that antisense
oligonucleotides targeting NSP9, ORF5 and ORF7, as
well as 5′UTR, will result in degradation of the viral
genome and inhibition of viral production.
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Antisense technology is one of the most promising
technologies allowing the use of a short complementary
oligonucleotide fragment to inhibit the expression of
the target mRNA at transcriptional as well as at post-
transcriptional levels. Antisense technology has the
advantage that it shows high specificity and selectivity
for the target gene sequence. Theoretically, antisense
molecules could be used to treat any disease that is
caused by the expression of a gene, e.g. viral infections,
cancer growth, and inflammatory diseases [7–9].
Some highly pathogenic PRRSV strains of the North
American type were found spread widely in more than
10 provinces in China and brought about four million
fatal cases in 2006 [10]. Therefore, it is imperative to de-
velop effective antiviral strategies to prevent and control
this infection. In the interest of exploiting improved
methods to control PRRS, we have applied the in silico
oligo-walk method and in vitro biological approaches
(cytopathic effect observation, quantitative PCR, virus
titer assay and indirect immunofluorescence staining) to
screen for protective antisense oligonucleotides that in-




Pigs used in this study did not undergo any manipula-
tion prior to standard industrial slaughter according to
the pertinent legislations. For this reason, no specific
ethical approval was required. All animal experiments
were performed with the approval of the Animal Care
Committee of Yunnan Agricultural University, China.
Virus and cells
The PRRSV field strain YN-1 (GenBank accession num-
ber: KJ747052), a highly pathogenic PRRSV belonging to
the North American genotype, was isolated in 2008 by
our research group from the lungs of an infected pig in
Yunnan province (China) during a severe PRRSV out-
break. It is known that the PRRSV can replicate in pul-
monary alveolar macrophages (PAM) or in MARC-145
cells, thus both culture systems were applied in this
study. The MARC-145 cell line was purchased from the
Shanghai Cell Collection, Chinese Academy of Sciences
(CAS), and cultured in Dulbecco’s modified Eagle’s
medium (DMEM, Invitrogen) supplemented with 10 %
heat-inactivated fetal bovine serum (FBS, GIBCO)
(pH 7.4), 2 mM L-glutamine, 100 U/ml penicillin and
100 μg/ml streptomycin (Invitrogen). The cultures were
maintained in a 5 % CO2 humidified incubator at 37 °C.
PAMs were obtained by post mortem lung lavage of 8-
week-old PRRSV free pigs, and seeded into 96-well
plates for 24 h incubation till further assays in RPMI-
1640 supplemented with 10 % fetal calf serum (FBS),
2 mM L-glutamine, 0.1 mM non-essential amino acids,
1 mM sodium pyruvate and a mixture of antibiotics.
Selection of antisense oligonucleotide sequences
Bo et al. [11] developed a database named AOBase
which stores 448 AS-ONs against the transcripts of 28
different target genes, and they found that the lengths of
the AS-ON in the database range from 10 nt to 22 nt,
with most of the AS-ONs 20 nt long. Therefore in this
study we designed and synthesized all AS-ONs with a
length of 20 nt.
Alignments of over 100 sequences (from NCBI data-
base) of each gene region were carried out, respectively.
Eight AS-ONs with 20 nt length (Table 1) directed
against the well-conserved regions of PRRSV with 100 %
sequence similarity (i.e., 5′-UTR, NSP9, ORF5 and
ORF7) were selected using RNA Structure 5.6 [12, 13].
We selected the most frequently occurring secondary
structure of the target RNA with minimal overall free
energy as a potential AS-ON target site. Specificity of
these sequences was verified by BLAST search. The posi-
tive AS-ON control (5UP2) studied by Patel et al. [14],
which is not fully complementary to the corresponding
5′UTR region of the YN-1 strain used in this study,
served as a negative control. This AS-ON control was
also modified to 5′-CGTGGCATAGAGCCAACACC-3′
here to serve as a candidate sequence for the YN-1
strain(5UP2*, see Table 1). The AS-ONs were synthe-
sized by Shengong (Shanghai, China).
The selection standards and procedures using RNAs-
tructure were described in details by Mathews [12].
Briefly, for an oligonucleotide to tightly bind to its com-
plementary sequence, the duplex free energy should be
low and the magnitude of the cost of opening the target
structure should also be minimized. The free energy of
duplex formation and the oligonucleotide self-structure
terms were previously shown to correlate with antisense
oligonucleotide efficacy [15].
Virus infection and transfection
The cells were trypsinized and plated in 96-well plates
(Corning) at 104 cells in 100 μl per well the day before
PRRSV infection and AS-ON transfection. The cells were
challenged with PRRSV YN1 strain (25 TCID50/well).
After 90 min inoculation, the medium was removed and
AS-ONs were transfected using 32 μM of AS-ONs in
100 μl of OPTI-MEM medium (Gibco) mixed with 1.5 μl/
well of Lipofectamine 2000 (Invitrogen) according to the
manufacturer’s instructions. Four hours post-transfection,
the transfection medium was replaced with fresh full
DMEM medium till further analysis. Each treatment was
performed in triplicates.
To measure the life time of AS-ONs in vitro, cy-3
labeled antisense oligonucleotide 5UP2 was used in the
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transfection. Cy-3 fluorescence signals were observed
under the fluorescence microscopy (Olympus) at various
time points (1, 2, 4 and 6 h post transfection) after re-
moval of the old medium, PBS wash and addition of
fresh medium.
Isolation of total RNA
Total RNA was isolated using the RNAiso Plus RNA
isolation kit from Takara (Dalian, China), as per the
manufacturer’s instructions. The RNA was quantified
using the absorbance at 260 nm and the purity assessed
from the ratio of absorbance at 260 and 280 nm. The
RNA used for all assays had a ratio of A260/A280 greater
than 1.90.
Reverse transcription and qPCR analysis
Total RNA was isolated and subjected to reverse tran-
scription and qPCR analysis. β-actin served as internal
control. The primer pairs used in this study are: 5′-atcca
ggctgtgctgtcc-3′ as forward primer and 5′-gaggatcttcatga
ggtagtcg-3′ as reverse primer for β-actin; 5′-gaacgctccct
ctgcttgc-3′ as forward primer and 5′-aaactcaacctgaaaacg
ttaccttc-3′ as reverse primer for ORF7. The ΔΔCt method
[16] for relative quantification of gene expression was used
to determine viral RNA levels. For analyzing the inhibitory
effect on RNA levels, SYBR Green real-time PCR was
performed. Briefly, reverse transcription was carried
out using Takara PrimerScript RT reagents kit in a vol-
ume of 10 μl at 37 °C for 15 min. One microliter of
reverse transcription reaction mixture was used for
qPCR by using gene-specific primers and master mix
from SYBR Primer Ex Taq II kit (Takara). All reactions
were performed in a 25 μl reaction volume. The
reaction was carried out at 95 °C for 30 s, followed by
35 cycles at 95 °C for 30 s and 60 °C for 5 s. Relative
amount of PRRSV RNA were normalized to β-actin
mRNA. Amplification and detection of samples were
performed with the CFX96 Touch Real-Time PCR De-
tection System (Bio-Rad).
Virus titration
Ten thousand Marc-145 cells were seeded into 96-well
plates the day before infection and transfection. A Ten-
fold serial dilution of PRRSV YN-1 strain was made with
medium. 100 μl/well of each dilution was added into six
wells. Ninety minutes post infection, the transfection
was performed as described above. CPE was monitored
using the inverted microscope over a period of 4 days
post transfection. Cell number was recorded and the
50 % tissue culture infected dose (TCID50) was deter-
mined by Reed–Muench method.
Indirect immunofluorescence staining
Sixty hours post PRRSV infection and transfection with
AS-ONs, medium was removed and the MARC-145
cells were fixed with 100 μl/well of 4 % paraformalde-
hyde (PFA) at room temperature for 15 min followed by
three washes with PBS (137 mM NaCl, 7 mM Na2HPO4,
1.5 mM KH2PO4, 2.7 mM KCl, pH 7.4), The fixed
samples were permeabilized with PBS containing 0.3 %
Triton X-100 for 15 min and blocked with PBS contain-
ing 1 % BSA for 2 h at 4 °C. The nuclei were stained
with 5 μg/ml of Hoechst 33,342 (Life Technology) in
PBS for 20 min at room temperature. Then the cells
were incubated with 5 μg/ml of PRRSV antibody against
N protein (encoded by ORF7) generated from mouse
Table 1 List of antisense oligonulceotides used in this study
Name of
AS-ON
















5UP2 5′-CAAGGCATAGAGCCAACACC-3′ 2 nt
mismatching
11–30 bp 55
5UP2* 5′-CGTGGCATAGAGCCAACACC-3′ 5′UTR 11–30 bp 60 −22.3 −24.9 0 −2.6 −6.8 68.9
YN1 5′-TGGGCTGTGCCAGTGGTCAC-3′ 5′UTR 52–71 bp 65 −20.6 −41.1 −15.7 −4.8 −12.6 93.1
YN2 5′-GATTGAAGGCAGTCTGGATC-3′ ORF7 234–253 bp 50 −16.1 −22.6 −5.9 −0.3 −5.7 67.2
YN3 5′-TGCAACTCCGGAAGCAAGGT-3′ 5′UTR 140–159 bp 55 −17.9 −25.4 −6.8 −0.5 −8 69.7
YN4 5′-CAGCTCACATAGCGTCAAAT-3′ ORF5 131–150 bp 45 −25.2 −36.1 −9.3 −1.5 −6.4 86.7
YN5 5′–CGTACGACGGTAGATGCTCT-3′ NSP9 1266–1285 bp 55 −23.5 −25 −0.4 −0.7 −7.8 69.6
YN6 5′-CGACGACAGACACAACTGCC-3′ ORF7 215–237 bp 60 −14.1 −24.5 −9.6 −0.6 −6.4 66.4
YN7 5′- CTGGATCGACAGACAGACACA-3′ ORF7 221–240 bp 55 −15.9 −38 −20.6 −1.4 −9.5 87.5
YN8 5′-TGCAGCATCCTCACAACCGT-3′ NSP9 704–723 bp 55 −23.1 −27.8 −4.7 0 −5.9 75.3
The thermodynamic parameters are free energy changes at 37 °C in kcal/mol. “Overall ΔG°37” is the total free energy change of binding for a structured target
and structured oligonucleotide. “Duplex ΔG°37” is the free energy change of duplex formation between the oligonucleotide and target. “Break Targ. ΔG°37” is the
free energy cost of opening target secondary structure. “Oligo Self ΔG°37” and “Oligo-Oligo ΔG°37” are the free energy costs of opening unimolecular and
bimolecular self-structure in the oligonucleotide, respectively. The Tm is the melting temperature of duplex formation in °C, not accounting for self-structure in
target or oligonucleotide
Zheng et al. BMC Veterinary Research  (2015) 11:199 Page 3 of 11
(VMRD, Cat. no. 080728–004) at 4 °C overnight. Cells
were washed three times with PBS and incubated with
Alexa Fluor 488 conjugated goat anti-mouse IgG (H + L)
antibody (Proteintech, Cat. no. 861163) at 5 μg/ml for
1 h at 37 °C. After three PBS washes the cells in the 96-
well plates were protected from light until further ana-
lysis by fluorescence microscopy (Olympus).
Statistical analysis
Software SPSS 11.0 and Student’s t-test were used to deter-
mine significant differences between treatments. A p-value
<0.05 was considered statistically significant. n-values
represent the number of independent experiments.
Results
Antisense oligonucleotide design
An effective AS-ON should be selected at the RNA re-
gions which are accessible for hybridization [17, 18]. To
select potent AS-ONs, the binding energy between the
AS-ONs and RNA (ΔG°37) should be as low as possible
(e.g., ≤ −8 kcal/mol), whereas the energy for binding
between AS-ONs should be as high as possible (e.g.,
ΔG°37 ≥ −1.1 kcal/mol) [19]. After analyzing some data
collected from > 1000 experiments, Matveeva et al. [15]
found a positive correlation between AS-ON mediated
RNA knockdown and the presence of CCAC, TCCC,
ACTC, GCCA and CTCT motifs in the AS-ONs, while
the presence of GGGG, ACTG, AAA and TAA motifs
in AS-ONs showed negative correlations. Ho et al. [19]
observed strong AS-ONs effects with a minimum of
11 G or C residues in 20 nt AS-ONs.
Nine AS-ONs were selected (Table 1) using the pro-
gram OligoWalk from the package RNAstructure to
calculate the binding energies of AS-ONs/AS-ONs and
AS-ONs/RNA. We tried to keep the AS-ONs contain-
ing ≥ 11 G or C, or any of the positive motifs (e.g.,
GCCA in sequence 5UP2* and YN1) and to exclude the
ones containing the negative motifs. Figure 1 illustrates
the complementary sequences of the targeting gene re-
gions for three AS-ONs showing prominent inhibitory
effects on PRRSV replication and demonstrates that the
local structures accessible to AS-ONs are those usually lo-
cated at the terminal end, internal loops, joint sequences,
hairpins and bulges of ≥10 consecutive nucleotides, as
previously reported by Kretschmer-Kaxemi et al. [20].
Life time of antisense oligonucleotides in in vitro cell
culture
To investigate how long AS-ONs are present in an in
vitro cell culture system, the Cy-3 labelled antisense
oligonucleotide 5UP2 was transfected into MARC-145
cells. At different time points (1, 2 , 4 and 6 h) post trans-
fection, the medium was removed, the cells were washed
with PBS, fresh medium was added into the wells, and
cells were imaged. (Fig. 2). We found that the fluorescent
signal from Cy-3 labelled antisense oligonucleotides was
still detectable 6 h post transfection, although the signal
decreased through the observation time period, demon-
strating that the antisense oligonucleotide is not de-
graded prior to PRRSV mRNA transcription and thus
can target to the viral mRNA for its degradation.
Inhibition of CPE by transfection with antisense
oligonucleotides
To investigate whether AS-ONs can protect MARC-145
cells from the cytopathic effect (CPE) induced by
PRRSV, cells were transfected with AS-ONs one and half
hours post challenge with 25 TCID50 PRRSV per well.
Treatments of no transfection, mock (Lipofectamin 2000
only, without any antisense sequence) and the 2 nt mis-
matching oligo 5UP2 served as negative controls. CPE
was recorded daily. An image for each treatment was
acquired 72 h post transfection and is shown in Fig. 3.
Significant cytotoxic effects were observed neither in the
mock well nor in the transfection well with 40 μM of
5UP2, but in the transfection well with 50 μM of 5UP2
(Fig. 3a), indicating that 40 μM of AS-ONs is a safe dose
for the cells. Therefore the working concentration
(32 μM) of AS-ONs in this study would not be toxic to
the cells, ruling out the possibility of inhibitory effects
due to the toxicity of different AS-ONs. In Fig. 3b, com-
pared with the normal cells (neither PRRSV inoculation
nor transfection was applied), the cells in the negative
controls aggregated, rounded up and disintegrated. We
found that cells transfected with 5UP2*, YN4, YN5 and
YN8 manifested overtly less CPE. Other AS-ON-treated
cells and the mock demonstrated the same typical
PRRSV-induced CPE as cells infected only with virus
(PRRSV only), which became pycnotic and detached
from the monolayer, demonstrating that those antisense
oligonucleotides do not show any obvious interference
with viral replication.
Reduction of viral RNA levels by transfection with
antisense oligonucleotides
To investigate whether AS-ONs inhibit PRRSV replica-
tion in MARC-145 cells and PAM, MARC-145 cells and
PAM were transfected by the selected AS-ONs. Non-
transfected MARC-145 cells and PAM challenged with
PRRSV were used as neutral control. Mock and transfec-
tion with 5UP2 were applied as controls for nonspecific
inhibition. When normalized to β-actin mRNA, similarly
in both Marc-145 and PAM, the ORF7 RNA level in the
cells transfected with AS-ONs YN8, 5UP2*, YN4 and YN5
were reduced by 85, 75, 70 and 70 %, respectively (Fig. 4).
There was no significant inhibition in cells transfected
with the other five AS-ONs and the 2 nt mismatching
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Fig. 1 (See legend on next page.)
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oligo 5UP2, suggesting that the reductions in ORF7 RNA
did not result from nonspecific inhibition or toxicity.
Reduction of viral titer by transfection with antisense
oligonucleotides
In order to further determine the level of inhibition,
CPE was monitored until 4 days post virus infection and
transfection. Viral titers were measured by TCID50
assay. We found that compared to the mock and 2-
nt mismatch 5UP2 control groups, transfection with
antisense oligonucleotide sequence YN8 significantly
protected Marc-145 cells from cytopathic effects
(Fig. 5a) and reduced the viral titer by 1000-fold
(Fig. 5b).
Fig. 2 AS-ON was present in cell culture six hours post transfection. Cy3-labelled antisense oligonucleotide 5UP2 (32 μM) was used in the transfection
in Marc-145 cells. The fluorescent signals were recorded with fluorescence microscopy (Olympus) at various time points post transfection. Cells are
shown to the left and the merged images (cells with fluorescent oligonucleotides) to the right. Although fluorescent signals decreased over the time,
we could still clearly observe the signals even six hours post transfection, indicating that the antisense oligonucleotide persist in Marc-145 cells for
sufficiently long time periods to induce the degradation of viral RNA and to inhibit PRRSV replication
(See figure on previous page.)
Fig. 1 Positions of the inhibitory AS-ON hits in the PRRSV gene regions. The lowest free energy secondary structures predicted for the PRRSV RNA
regions were drawn by RNAstructure. The full RNA secondary structure of PRRSV 5′UTR is shown in A, while the partial RNA secondary structures
of PRRSV ORF5 and NSP9 are shown in B and C, respectively. The complementary regions between the AS-On hits (5UP2*, YN4 and YN8) and their
corresponding targets were highlighted in yellow: 5UP2* targeting 5′UTR, YN4 targeting ORF5 and YN8 targeting NSP9
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Fig. 3 Cytopathic effect (CPE) analysis of porcine reproductive and respiratory syndrome virus (PRRSV) in MARC-145 cells transfected with
AS-ONs. a. Comparing with the mock treatment, transfection with 50 μM antisense oligonucleotide 5UP2 showed significant cytotoxicity,
while transfection with 40 μM did not. b. Four out of nine selected antisense oligonucleotides demonstrated significant (5UP2* and YN8)
or moderate (YN4 and YN5) protection from challenge with PRRSV YN-1 strain. Pictures were taken 72 h post infection with a Nikon
E5400 camera mounted on an inverted microscope (Nikon TS100)
Fig. 4 Viral ORF7 RNA level was reduced by transfection with selected antisense oligonucleotides in both Marc-145 and PAM cells. Four of the
nine selected antisense oligonucleotides (5UP2*, YN8, YN4 and YN5) significantly inhibited the RNA level of gene ORF7. After virus challenge
and transfection with AS-ONs under the same conditions as in the CPE analysis experiment, total RNA was isolated and subjected to reverse
transcription and qPCR analysis. The ΔΔCt method for relative quantification of gene expression was used to determine viral RNA levels. The
Y-axis shows the relative RNA levels of the ORF7 gene for each treatment after normalization to the non-transfected reference sample using
β-actin as internal control. The values shown are means of three independent experiments
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Abrogation of viral protein level by transfection with
antisense oligonucleotides
To investigate the effect of AS-ONs on inhibiting the
expression of viral protein, indirect immunofluores-
cence assays were performed with anti-N protein mAb
(encoded by gene ORF7) 60 h post transfection. Indeed,
fewer fluorescing cells were seen in the monolayers
treated with YN8 and 5UP2* than in the other mono-
layers, while transfection with YN4 and YN5 mildly
reduced the viral N protein level. In contrast, the in-
fected cells in wells pre-transfected with YN1, YN2,
YN3, YN6 and YN7 had equivalent or slightly less N
Fig. 5 The antisense oligonucleotide sequence YN8 protected PAM from cytopathic effects and reduced the viral titer by 1000 fold.
Pulmonary alveolar macrophages (PAM) (10 000 cells per well) were seeded into 96-well plates the day before infection and transfection.
Ten-fold serial dilution of PRRSV YN-1 strain was made with medium. 100 μl/well of each dilution was added into six wells. Ninety
minutes post infection, the transfection was performed. CPE was monitored using the inverted microscope over a period of 4 days post
transfection. The 50 % tissue culture infected dose (TCID50) was determined by Reed–Muench method. Comparing to the mock and 2-nt
mismatch 5UP2control groups, transfection with antisense oligonucleotide sequence YN8 significantly protected the PAM from cytopathic
effects (a) and reduced the viral titer by 1000-fold (b)
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protein-positive cells compared to that of controls
(i.e., mock and transfection with the 2 nt mismatch-
ing oligo 5UP2, Fig. 6).
Discussion
PRRSV is recognized as one of the most important vi-
ruses for swine industry. It can persist in pigs for quite
long time after initial infection, and infected animals
with persistent infection can shed infectious virus for
several months. Many scientists have been putting a lot
of efforts into developing various shRNA or siRNA
methods to suppress PRRSV replication in vitro and in
vivo [21–27], and only few studies have used antisense
technology [14, 28]. However, it is well known that
antisense technology has outperformed siRNAs to some
extent [29, 30], as it is easy and quick to design an anti-
sense against a gene target, to produce the antisense
sequence effectively in scale using standard equipment
and procedures at lower cost and its modified deriva-
tives that offer greater stability and efficacy, to deliver
AS-ONs into cells.
Therefore, in this study we aimed to design AS-ONs
targeting PRRSV regions of 5′UTR, ORF5, ORF7 and
NSP9, and to test the inhibitory effects of these AS-ONs
without any chemical modifications in cell culture.
Under the conditions of this study, four out of the nine
selected AS-ONs showed prominent inhibitory effectson
PRRSV replication. The reasons for the ineffectiveness
of the other AS-ONs are unclear, but could include the
inaccessibility of the target sequence, or difficulties in
secondary structure prediction of viral RNA. Alterna-
tively, successful AS-ON/target RNA duplexing might
not necessarily affect PRRSV replication. However,
compared with the reported hit rates (approx. 10 %
[31], 4/34 [32] or 4/12 [14]), we achieved higher ‘suc-
cess rate’ (44 %). As shown in Table 1, the four effective
AS-ONs have the lowest value of overall ΔG°37, indi-
cating that the binding between the antisense oligo-
nucleotide and its corresponding target sequence might
be very stable. However, no obvious conclusions could
be drawn regarding the efficacy and specific motifs or
GC content in the AS-ON sequences. Larger sets of
Fig. 6 Indirect immunofluorescence detection of PRRSV in MARC-145 cells transfected with or without AS-ONs. Transfection was performed
90 min post infection with PRRSV YN-1 strain (25 TCID50). Cells were fixed 60 h post transfection, reacted against anti-N monoclonal antibody
(MAb) and then incubated with fluoresce in Alexa Fluo488 conjugated secondary antibody. Blue color stains nuclei to show the total number of
cells. The green color indicates the expression of N protein in MARC-145 cells. The images of the same treatment from the two channels were
merged. Treatment with YN8, 5UP2*, YN4 and YN5 resulted in reduction of virus replication, while 5UP2 and the other AS-ONs did not appear to
have obvious effects under identical conditions
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AS-ONs should be tested to obtain more statistically
significant data.
Blasting the four inhibitory AS-ONs revealed that
these sequences are highly conserved and hit more
than 100 PRRSV strains of the Northern American
type, with most of them reported from China. This
suggests that that these AS-ONs should inhibit the
replication of Northern American strains of PRRSV
prevalent in China, not only limited to the YN-1 stain
which was isolated from the southwest of China, and
thus can be considered as potential drug candidates for
use in PRRSV control.
Conclusion
In conclusion, this study demonstrates that DNA-based
short antisense oligonucleotides can effectively inhibit
PRRSV replication in MARC-145 cells and in PAMs.
The experimental results which are based on the CPE
experiments, measurement of the viral ORF7 RNA level
and indirect fluorescence staining, demonstrated that
MARC-145 cells transfected with AS-ON 5UP2* (target-
ing 5′-UTR) and YN8 (targeting NSP9) showed a signifi-
cant decrease in virus replication when compared to the
2 nucleotide mismatching negative control (AS-ON
5UP2), indicating the specificity of the antisense oligo-
nucleotides; while transfection with YN4 or YN5 also
inhibited the PRRSV replication to some extents. It in-
fers that 5′-UTR or NSP9 might be one of the optimal
viral targets to design AS-ONs. However, the natural
phosphodiester oligodeoxynucleotides (DNAs) used in
this study could be relatively quickly degraded by nucle-
ases. When it comes to the actual in vivo application of
AS-ONs in therapeutic control of PRRSV, we plan to
add some locked nucleic acid (LNA) modifications to
the four promising AS-ON sequences for further studies
both in vitro and in vivo, in order to increase the stabil-
ity of AS-ONs and the cellular uptake, to enhance the
hybridization affinity towards target mRNA and to
reduce the toxicity, to investigate the techniques and
efficiency of delivery, to study the temporary effects and
to address the issue of emergence of escape mutants.
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